Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

SaaS market struggling but pockets of resilience remain, finds new report from OpenView and Paddle

Published

on

saas-market-struggling-but-pockets-of-resilience-remain,-finds-new-report-from-openview-and-paddle
  • 2023 has been marked by a slowdown in growth for both public and private software providers as their customers scrutinise cloud spend and delay purchases
  • New report reveals how players in the space are remaining resilient – the ‘Outlier’ companies – as well as the shifting priorities of SaaS founders

LONDON, Nov. 8, 2023 /PRNewswire/ — Software-as-a-service (SaaS) companies saw their annual revenue growth rate fall to just 8.4% in September 2023 – down from 60% in Q1 2022 – according to a new study from venture firm OpenView and payments infrastructure provider Paddle. Leveraging data from thousands of companies worldwide, the 2023 OpenView SaaS Benchmarks Report charts the state of the cloud industry and the priorities of its leaders, revealing a significant industry slowdown but also areas of resilience. The study also highlights what SaaS firms are doing to remain competitive during this period.

2023 has been a turbulent year for the software industry. Breakthroughs in AI have restored confidence in the transformative power of software, buoying public SaaS valuations – the top software giants have added $2.4trn in market cap over the last year – and driving huge VC investment, with funding for AI startups passing $14 billion in Q2 2023 alone. Yet at the same time, SaaS customers of all sizes have continued to tighten budgets and reduce spending, making growth  harder to come by for both established and smaller providers.

Data from the SaaS Benchmarks Report shows that: 

  • Smaller SaaS providers have been hardest hit: the biggest fall in median YoY revenue growth recorded was for private companies with between $520m ARR. This group saw growth fall 26 percentage points (from 61% in 2022 to 35% in 2023); and for bigger firms with $2050m ARR it fell by 16 percentage points (from 40% to 24%).
  • Public companies are also impacted: public software firms with product-led growth (PLG) strategies have also seen their revenue growth from the last 12 months drop by 16 percentage points (from 45% to 29%) when comparing Q2 2023 to Q2 2022.
  • Overall growth has dropped dramatically: the compound annual growth rate for all SaaS companies stood at 8.4% as of September 2023, a huge drop from 60% in Q1 2022.

The study also reveals founder anxieties amid the current economic climate and shifting business priorities of SaaS leaders:

  • When asked to list the top three issues keeping them up at night, 73% of SaaS founders listed GTM execution, 50% listed product execution, and 32% listed burning too much cash. By comparison, only 59% of founders were worried about GTM in 2021, and only 13% were concerned about cash flow. Moreover, despite rising industry emphasis on forming AI strategies, the average SaaS founder is yet to consider AI a top three priority in 2023.
  • SaaS companies are increasingly focusing on profitability over a ‘growth at all costs’ mentality. While PLG SaaS companies have seen their revenue growth over the last 12 months fall, their profitability has increased by 10 percentage points over the same period – indicative of the new mindset of many SaaS leaders.
  • SaaS fundraising has focused on seed stage companies:  for SaaS companies at the seed stage, 30% of their funding rounds occurred in the last 6 months. However, later stage businesses have not been raising at the same frequency: 55% of Series B companies last raised 1-2 years ago while 38% of Series C rounds were over 2 years ago.

What makes an Outlier?

OpenView and Paddle also identified four traits that nimble SaaS businesses – the ‘Outliers’ – are doing to remain resilient despite slowing demand:

  • Using AI to generate revenue.  Despite the rush to deploy AI, only a minority of firms have been able to monetise AI-powered functionality.

         ○  AI-native companies are 230% more likely to be in the “growing faster” bucket than their peers – but they are only represented in 10% of ‘Outlier’ companies.

         ○  This is because most firms are yet to monetise their AI capabilities. Nearly half (46%)  of companies added AI to their product in the last year, but only 15% of respondents – the Outliers – launched and monetised AI features.

  • Managing burn. Slowing revenue growth and reduced access to venture funds have made managing burn crucial, and many firms have cut down costs.

         ○  The median number of employees for firms with over $50m ARR dropped to 450 in 2023 from 876 in 2022. This slimming down has helped many ‘Outliers’ get in control of their burn rate and build more resilient businesses.

         ○  When it comes to ARR per full time employee (FTE) – a common indicator of productivity – SaaS startups are expected to hit $200k$250k ARR per FTE when they reach scale. The report found that for firms with a team of 450 with over $50m ARR, this stood at $250k – indicating that productivity remains strong post-layoffs.

  • Operational efficiency. SaaS startups are learning to do more with less, automating manual work and optimising processes:

         ○  The tougher market has forced companies to revisit their pricing. Over half the respondents said they had changed their pricing and packaging to improve their net dollar retention.

         ○  Offering more payment methods is also crucial for securing conversions internationally. For example, in Germany, PayPal is the most preferred payment option – but only 13% of our US respondents offer it.

         ○  A quarter of respondents said finance, tax and compliance cost them between 5-9% of ARR. Worryingly, 27% said they didn’t know or didn’t track these as a cost at all.

  • Focusing on product-led expansion revenue, which has become more important than ever in the current macroeconomic environment.

         ○  Self-serve onboarding and freemium models have become king in recent years, and these models see 90% of their revenue as product-influenced (paying customers who use the product before ever talking to a human salesperson) for SaaS companies that take advantage of them.

Commenting on the launch of the report, Paddle Chief Marketing Officer Andrew Davies, said: “2023 has undoubtedly been a challenging year to scale a software business, with revenue growth rates for SaaS firms falling from 60% in 2022 to just 8.4% in September 2023. The good news however is that the industry is still growing, and we’re seeing pockets of resilience from firms who share some notable traits.  Today’s outliers are those that focus on monetising the benefits of AI, increasing operational efficiency, and driving product-led expansion revenue while managing their burn rate. By moving away from the growth-at-all-costs mentality of the last few years and prioritising scaling in a smart and sustainable way, companies can continue to thrive and grow in a way that outpaces the market.”

Kyle Poyar, Partner at OpenView, said: “Last year, the SaaS industry was still growing rapidly, and ambitious companies in the space had plenty of cash runway from recent financings. But, as our new report shows, 2023 has been quite different. Sales have dried up as businesses large and small have delayed purchases, lengthened deal timelines, and scrutinised their cloud spend. Venture funding has also slowed down, and a third of founders are now concerned about burning too much cash – compared to just 13% in 2022. However, software remains mission critical as enterprises continue to accelerate their digital transformation, and – as our report demonstrates – there are still growth opportunities for firms that keep efficiency and sustainable growth top of mind.”

You can read the full results from the 2023 OpenView SaaS Benchmarks Report here: https://openviewpartners.com/2023-saas-benchmarks-report/

Methodology

This report is based on qualitative and quantitative research into the global SaaS market. The report combines over 3,500 respondents’ results aggregated across seven years of surveying private SaaS businesses on their finance and operating metrics.

About Paddle

Paddle, the payments infrastructure provider for B2B SaaS companies, powers hyper-scale growth across acquisition, renewals and expansion. With Paddle, companies are finally able to transform their payments infrastructure into a strategic growth lever to respond faster and more precisely to every growth opportunity. Paddle has 300 employees serving over 4,000 software sellers in 245 countries and territories globally. Backed by investors including KKR, FTV Capital, Kindred, Notion, and 83North, Paddle aims to define the next wave of B2B SaaS leaders. Visit www.paddle.com or www.twitter.com/PaddleHQ for more information

About OpenView

OpenView is a venture capital firm on a mission to change the way the world works. OpenView invests globally in business software companies at the expansion stage – where companies have found early product-market fit and are ready to scale. Pre-and post-investment, OpenView’s Expansion team has the operational expertise to work with companies on sales, marketing, product-led growth, pricing, talent, corporate development and other initiatives. Founded in 2006 and headquartered in Boston with a presence in New York City and Los Angeles, OpenView has $2.4B in total assets under management and is actively investing out of its seventh fund, a $570M vehicle raised in 2023. For more information, visit openviewpartners.com

Press:
Paddle: [email protected]
OpenView: [email protected]

         

 

View original content:https://www.prnewswire.co.uk/news-releases/saas-market-struggling-but-pockets-of-resilience-remain-finds-new-report-from-openview-and-paddle-301981634.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending